An updated guide to timing, parts, costs and coordination so you don’t get stuck with penalties or surprises at 65.
TipRanks on MSN
Liquidia Technologies Secures Licensing Deal with Vectura
An announcement from Liquidia Technologies ( ($LQDA) ) is now available. On October 27, 2025, Liquidia Technologies entered into an exclusive ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio-Antibiotic is primarily used for ...
Texas officials promised to help Rochelle care for her grandkids after taking them from their parents. But the help she ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has commenced an underwritten public offering of shares of its ...
Zacks Investment Research on MSN
CRMD vs. TBPH: Which Small-Cap Biotech Stock Is the Better Buy?
In the competitive world of small-cap biotechnology, CorMedix CRMD and Theravance Biopharma TBPH stand out as two companies ...
Savara Inc. , a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the pricing of an underwritten public offering of 23,809,524 shares of its common stock ...
The market is rapidly advancing, driven by the demand for smaller, more powerful batteries for wearable and remote monitoring ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced a $75 million royalty funding agreement with funds managed by RTW ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback